Males with early-onset colorectal cancer are at risk, according to a study.

Published Date: 28 Jun 2023

Incidence and fatalities from colorectal cancer are decreasing in people 50 and older, but rising in people under 50.

Read Full News

Latest News

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Here's Why Hematuria in a Young Patient Should Always Be Investigated

Terminology also makes a difference

Liver Failure or Liver Mets?

Diagnosis complicated by absence of radiologic evidence of hepatic lesions

Todays Updates

A Surgical First for Removal of an Appendiceal Neoplasm

Technique deemed safe and feasible for selected patients and better than other minimally invasive approaches

What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?

Cardiomyopathy risks interrupting cancer treatment, worsening prognosis

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

— News, features, and commentary about cancer-related issues

Todays Updates

A Surgical First for Removal of an Appendiceal Neoplasm

Technique deemed safe and feasible for selected patients and better than other minimally invasive approaches

What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?

Cardiomyopathy risks interrupting cancer treatment, worsening prognosis

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

— News, features, and commentary about cancer-related issues

Latest News

Case shows importance of accurate preop diagnosis

Some panelists had reservations about the test's true benefit, however

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Terminology also makes a difference

Diagnosis complicated by absence of radiologic evidence of hepatic lesions

News All Time

Cancer Diagnosis, Then a Stroke; 9/11 Cancer Deaths; 'Grand Slam' Drug and Price

News, features, and commentary about cancer-related issues

Local Consolidative Therapy After Dual Immunotherapy Fizzles in Metastatic NSCLC

Overall survival favored nivolumab-ipilimumab alone in LONESTAR trial

Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancer

Death risk cut by 54% with B7-H3-targeting tambotatug pelitecan and risvutatug rezetecan

No Survival Bump in Metastatic NSCLC With Addition of ADC to Immunotherapy

Non-significant 4-month PFS increase with sacituzumab govitecan-pembrolizumab, no OS benefit

Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer

Omitting prophylactic cranial irradiation led to improved cognitive failure-free survival

Nurse Accused of Exorcism; Death After 8 Hours of Plastic Surgery; Top Cancer Months

Health news and commentary gathered by MedPage Today staff

Cancer Drug Shortages Continue With No Immediate Path Toward Relief

All responding NCCN members reported shortages, priorities identified but solutions still needed

ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate

Early efficacy among the highest seen in lung cancer, expert says

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

Bispecific antibody and ADC together impress in early study

Novel Drug Cuts Risk for Death by 44% in Squamous Lung Cancer Trial

If approved, immunotherapy gotistobart could offer a chemo-free option in second-line setting

Unprecedented PFS in HER2-Mutant Lung Cancer, but With a Touch of Controversy

Practice-changing median of 14.3 months with T-DXd, but caution over early unfavorable OS trend

Woman Develops Tiny Blood Spots on Her Body After COVID Shot

Case highlights need for quick diagnosis and management of rare disorder

Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status

Ivonescimab topped pembrolizumab alone or paired with chemotherapy in separate trials

Patient's Colonoscopy Refusal Highlights Value of CRC Screening

Man with a first-degree relative with CRC initially only agreed to stool-based testing

RFK Jr. Eyes Wireless, RF Radiation; Cancer by the Month; AI for Cancer Symptoms

News, features, and commentary about cancer-related issues

FDA Staff Find No Major Concerns With Galleri Multicancer Early Detection Test

— Comments were noncommittal in agency document released ahead of advisors' meeting

Recommended News For You

Males with early-onset colorectal cancer are at risk, according to a study.

How to keep your prostate healthy and lower your risk of developing serious problems

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

What Caused This Young Man's Bladder Cancer

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.

Parkinson patient's gait is restored by a spinal cord stimulator.

Surgery may not be necessary to treat invasive breast cancer

Recommended Articles For You

National Blood Health Promotion Strategies: Evidence-Based Approaches for Improved Outcomes 

Engineering the Future of Oncology with CAR- Natural Killer Cell Design & Therapeutics 

Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy 

The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

2.

According to a study, breast cancer cells work together to physically breach barriers and proliferate.

3.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

4.

Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.

5.

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

1.

Emerging Insights in Hematology for Better Care

2.

An Overview Of Leukemia Cutis: What It Is And How To Treat It

3.

Rehabilitation After Function-Preserving Oncologic Reconstruction

4.

Exercise Capacity During Cancer Recovery: Mechanisms, Clinical Implications, and Evidence-Based Management

5.

Oncology Communication Simulation: Enhancing Clinical Competence Through Evidence-Based Training

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

3.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

5.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot